Procept BioRobotics faces market, safety criticism from short seller Spruce Point Capital Management
Procept’s recent launch of the Hydros system, which uses artificial intelligence, also faced skepticism from Spruce Point.
More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback